

CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 50 TABLETS x 1 MG
ACTIVE HALF-LIFE: ~48 HOURS
DOSAGE: 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: AXIOLABS
Arimiplex 1 by Axiolabs provides 1 mg of pharmaceutical-grade Anastrozole per tablet — a highly effective aromatase inhibitor (AI) used to control estrogen levels during anabolic steroid cycles. It prevents the conversion of testosterone into estrogen, thereby minimizing side effects like water retention and gynecomastia.
Anastrozole is a third-generation non-steroidal aromatase inhibitor originally developed to treat estrogen-sensitive breast cancer. In bodybuilding, it's widely used to reduce estrogenic side effects and maintain a dry, hard physique while optimizing testosterone levels.
Common dosing is 0.5–1 mg every other day during steroid cycles involving aromatizing compounds. Advanced users may adjust based on bloodwork. Due to its long half-life (~48 hours), frequent dosing isn't required.
Arimiplex is ideal when using testosterone-based compounds such as:
It may also be used during PCT or TRT to manage estrogen ratios effectively.
For complete on-cycle support, Arimiplex stacks well with:
We offer original Arimiplex 1 mg by Axiolabs with fast U.S. shipping. Explore our complete Axiolabs steroid catalog for AIs, PCT solutions, and advanced hormone support.
Scientific reference: PubMed: Clinical pharmacology of Anastrozole.
Start Arimiplex when using aromatizing steroids like testosterone. Begin with 0.5 mg EOD and adjust based on side effects or bloodwork.
Yes. Arimiplex can help regulate estrogen during post-cycle therapy, especially if estrogen rebound is a concern.
No, it blocks estrogen conversion and may increase free testosterone by lowering circulating estrogen levels.
Please log in to write ARIMIPLEX 1 MG review.
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 50 TABLETS x 50 MG
ACTIVE HALF-LIFE: 5-7 DAYS
DOSAGE: MEN 25–100 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): REDUCED RISK
HEPATOTOXICITY: NO
AROMATIZATION: PERMANENTLY BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 50 TABLETS x 20 MG
ACTIVE HALF-LIFE: ~5–7 DAYS
DOSAGE: MEN 10–40 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: BLOCKED AT RECEPTOR LEVEL
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: 0.25–1.25 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED (POTENT)
MANUFACTURER: AXIOLABS